Prostatic Neoplasms: all 6,484 studies
Page 40 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized StudyStatus unknownNCT03600766Phase 2
- Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand TherapyWithdrawnNCT03596710Not applicable
- Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the ProstateWithdrawnNCT03589781Not applicable
- Stereotactic MRI-Guided Radiation for Localized Prostate CancerStatus unknownNCT03588819Not applicable
- A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate CancerStatus unknownNCT03587285Phase 1/2
- Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based BiomarkersActive, not recruitingNCT03585114Phase 2
- Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical ProstatectomyActive, not recruitingNCT03582774Phase 3
- Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate CancerWithdrawnNCT03581500Phase 2
- Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen TherapyCompletedNCT03580499Not applicable
- Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway DeficiencyStatus unknownNCT03580239Phase 3
- Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active SurveillanceStatus unknownNCT03579654Phase 2
- Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their PartnersActive, not recruitingNCT03575832Not applicable
- A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT03575819Phase 1
- A Study to Test Radium-223 With Docetaxel in Patients With Prostate CancerActive, not recruitingNCT03574571Phase 3
- Methionine-Restricted Diet to Potentiate The Effects of Radiation TherapyTerminatedNCT03574194Not applicable
- PSMA PET/CT for Prostate CancerCompletedNCT03573011Phase 2
- Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer DetectionStatus unknownNCT03572946Not applicable
- Development and Evaluation of a Therapeutic Education Intervention in Prostate Cancer Patients Treated With Radical Prostatectomy to Improve Their SexualityStatus unknownNCT03572621Not applicable
- Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC PatientsCompletedNCT03569280Phase 1
- PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer MetastasesActive, not recruitingNCT03569241Phase 2
- Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate CancerCompletedNCT03568188Phase 2
- PRospective Prostate biOmarker StudyCompletedNCT03565289
- Proton Boost in Prostate CancerActive, not recruitingNCT03564275Not applicable
- A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223CompletedNCT03563014
- Clinical Trial for a Robotic Endomicroscopy to Better Define Resection Strategies Applied to Urology SurgeryStatus unknownNCT03561857Not applicable
- A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate CancerActive, not recruitingNCT03561220Not applicable
- PSMA-PET/CT for Prostate CancerCompletedNCT03558711Phase 1
- An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net HospitalTerminatedNCT03553732
- Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) BrachytherapyTerminatedNCT03553212Not applicable
- A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate CancerCompletedNCT03551782Phase 1
- 3D Versus Robot Assisted Laparoscopic Prostatectomy.TerminatedNCT03550040Not applicable
- Evaluation of Oncoxin-Viusid® in Prostate CancerCompletedNCT03543670Phase 2
- Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation TherapyCompletedNCT03543189Phase 1/2
- Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & SurgeryStatus unknownNCT03541928Phase 2
- Novel Imaging in Staging of Primary Prostate CancerCompletedNCT03537391Not applicable
- Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic SurgeryCompletedNCT03536065Not applicable
- Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation TherapyCompletedNCT03535987
- PSMA PET Registry (18F-DCFPyL)CompletedNCT03535831Not applicable
- Biomarkers in Prostate Cancer Treated With SRP Following Failure of FATStatus unknownNCT03533998
- Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate CancerCompletedNCT03532217Phase 1
- Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate CancerActive, not recruitingNCT03531099Phase 3
- Effect of Anesthetic Method on Optic Nerve Sheath Diameter in Patients Undergoing RALPCompletedNCT03529643Not applicable
- Prostate Cancer Patients With Biochemical RecurrenceCompletedNCT03527199
- Exercise Prescription Dose for Castration Resistance Prostate Cancer PatientsCompletedNCT03526562Not applicable
- Hypofractionated Boost vs Conventionally Fractionated Boost for Localized High Risk Prostate CancerStatus unknownNCT03526510Not applicable
- Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer TreatmentStatus unknownNCT03525652Phase 1/2
- PSMA-PET Guided RadiotherapyActive, not recruitingNCT03525288Phase 2/3
- Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer PatientsCompletedNCT03524391Not applicable
- A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT03523442Phase 1
- An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate CancerNo longer availableNCT03523338
- Patient-Centered Communication of Life Expectancy Estimates in Genitourinary MalignanciesStatus unknownNCT03522155Not applicable
- A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate CancerActive, not recruitingNCT03520478Phase 3
- Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist TherapyCompletedNCT03516110
- A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate CancerStatus unknownNCT03516045Phase 1/2
- Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After SurgeryCompletedNCT03515577Phase 2
- High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate CancerWithdrawnNCT03514927Not applicable
- A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate CancerTerminatedNCT03514836Phase 1/2
- Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate CancerCompletedNCT03513211Phase 1/2
- Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® TestingCompletedNCT03511235
- Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate CancerActive, not recruitingNCT03511196Early Phase 1
- A Study of IMP4297 in Patients With Advanced Solid TumorsCompletedNCT03508011Phase 1
- Early Staged Consent Before Prostate BiopsyCompletedNCT03507725Not applicable
- Evaluation of the Metastasis and Recurrence of Prostate CancerStatus unknownNCT03507595
- The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid TumorsCompletedNCT03507543Phase 1
- Efficacy and Safety Assessment of IRE of Localized Prostate Cancer.CompletedNCT03504995Not applicable
- ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue EvaluationStatus unknownNCT03504761Not applicable
- Hemi-Gland Cryoablation for Prostate Cancer at UCLACompletedNCT03503643
- Genetic Testing for Men With Metastatic Prostate CancerTerminatedNCT03503097
- Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active SurveillanceCompletedNCT03502213
- F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate CancerNo longer availableNCT03501940
- A Study of Participants With Advanced Prostate Cancer in CanadaCompletedNCT03501173
- Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.CompletedNCT03497377Phase 1
- Aneustat Treatment of Localized Prostate Cancer Under Active SurveillanceWithdrawnNCT03495479
- Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMCWithdrawnNCT03494803
- 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate CancerTerminatedNCT03490838Phase 1
- Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate CancerWithdrawnNCT03488810Phase 3
- Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA LevelStatus unknownNCT03488706
- PSMA-PET Imaging in Patients With Metastatic Prostate Cancer: Institutional Evaluation of Detection Yield Performance and ReproducibilityCompletedNCT03486886Not applicable
- Collection of Blood in Studying Metabolites in Patients With Prostate CancerTerminatedNCT03485794
- Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder InvasionStatus unknownNCT03482089Not applicable
- Staple vs. Suture in Robotic ProstatectomyCompletedNCT03480074Not applicable
- Learning Curve of Digital Rectal Examination for Prostate Cancer Among InternshipStatus unknownNCT03479359
- Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate CancerWithdrawnNCT03477864Phase 1
- Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening DecisionsCompletedNCT03477591Not applicable
- An Observational Prospective Cohort Study Using an Actigraphy Device.CompletedNCT03475433
- Ischemic Heart Disease in Male With Prostate AdenocarcinomaStatus unknownNCT03474835Not applicable
- Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate CancerActive, not recruitingNCT03471650Phase 2
- Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.TerminatedNCT03465579Not applicable
- Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer PatientsWithdrawnNCT03465345Phase 1
- Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer SurvivorsWithdrawnNCT03459755Not applicable
- Pre-Operative Single Shot Rectus Sheath BlockCompletedNCT03458598Not applicable
- Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal TherapyStatus unknownNCT03458559Phase 3
- Study of Dose Escalation of Abiraterone Actetate in Prostate CancerCompletedNCT03458247Phase 2
- Prostatic Artery Embolization in Advanced Prostate CancerStatus unknownNCT03457805Not applicable
- Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)CompletedNCT03454750Phase 2
- Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate CancerStatus unknownNCT03451812
- A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate CancerCompletedNCT03450109Phase 1
- Phase II Randomized Trial of Radiation Therapy in Oligometastatic mCRPC Prostate Cancer (ARTO)Status unknownNCT03449719Not applicable
- Effect of TyG Index on Outcomes of Radical ProstatectomyCompletedNCT03447028
- Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate CancerActive, not recruitingNCT03444844Phase 1/2